Tag: OPTI
Optimi Health Announces Canadian Retail and E-Commerce Distribution Agreements for Functional Mushroom Supplements and Appoints Chief Financial Officer to its Board of Directors
VANCOUVER, British Columbia, Aug. 25, 2022 (GLOBE NEWSWIRE) — Optimi Health...
Read More
Health Canada Grants MDMA Production and Distribution Amendment to Optimi Health
CEO says licensing amendment positions Optimi to be a “global leader in the safe supply of EU-GMP...
Read More
Optimi Health Provides Dealer License Update and Comments on Health Canada’s Amendments to the Special Access Program (SAP)
SAP amendment allows practitioners to request access to psychedelic drugs for patients with...
Read More
Optimi Health Receives Dealers License Inspection and Introduces Quality Assurance Department
VANCOUVER, British Columbia, Dec. 21, 2021 (GLOBE NEWSWIRE) — Optimi Health...
Read More
OPTIMI HEALTH STRENGTHENS CLINICAL AND REGULATORY EXPERTISE
VANCOUVER, BC ( July 27, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi”...
Read More
OPTIMI HEALTH JOINS FIRST PSYCHEDELIC EXCHANGE TRADED FUND
VANCOUVER, BC (July 13, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi”...
Read More
OPTIMI HEALTH INITIATES PATHWAY TO NASDAQ LISTING
VANCOUVER, BC (July 7, 2021) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi”...
Read More
Optimi Health Completes OTC Markets Uplisting to OTCQB
VANCOUVER, British Columbia, June 17, 2021 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE:...
Read More
Optimi Health Completes Pre-Clinical Trial Application Meeting
Company Advised by Health Canada to Proceed with Phase 1 Psilocybin Study Application VANCOUVER,...
Read More
Optimi Health Announces Product Distribution Agreement with Vitasave
VANCOUVER, British Columbia, June 08, 2021 (GLOBE NEWSWIRE) — Optimi Health...
Read More
